Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravenous Albumin Infusion Does not Augment the Response Rate to a Combination of Exclusive Enteral Nutrition and Intravenous Steroids in Acute Severe Ulcerative Colitis: A Randomised Controlled Trial.
Mundhra SK, Madan D, Golla R, Sahu P, Vuyyuru SK, Kante B, Kumar P, Mathew Thomas D, Prasad S, Vaishnav M, Verma M, Virmani S, Bajaj A, Markandey M, Ranjan MK, Arora U, Singh MK, Makharia GK, Ahuja V, Kedia S. Mundhra SK, et al. Among authors: ranjan mk. J Crohns Colitis. 2024 Nov 4;18(11):1870-1878. doi: 10.1093/ecco-jcc/jjae094. J Crohns Colitis. 2024. PMID: 38881153 Clinical Trial.
"Prevalence, Predictors, and Impact of Hepatic Steatosis in Patients With Ulcerative Colitis: A Prospective Observational Cohort Study".
Gupta A, Vuyyuru SK, Kante B, Kumar P, Farooqui M, Ranjan MK, Singh N, Mundhra SK, Madan D, Golla R, Singh N, Makharia G, Kedia S, Ahuja V. Gupta A, et al. Among authors: ranjan mk. J Clin Exp Hepatol. 2024 Mar-Apr;14(2):101293. doi: 10.1016/j.jceh.2023.10.004. Epub 2023 Oct 12. J Clin Exp Hepatol. 2024. PMID: 38076443
Thiopurines Have Sustained Long-term Effectiveness in Patients with Inflammatory Bowel Disease, Which is Independent of Disease Duration at Initiation: A Propensity Score Matched Analysis.
Ranjan MK, Kumar P, Vuyyuru SK, Kante B, Mundhra SK, Golla R, Virmani S, Sharma R, Sahni P, Das P, Kalaivani M, Upadhyay AD, Makharia G, Kedia S, Ahuja V. Ranjan MK, et al. J Crohns Colitis. 2024 Feb 26;18(2):192-203. doi: 10.1093/ecco-jcc/jjad135. J Crohns Colitis. 2024. PMID: 37584328
Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring.
Kumar P, Vuyyuru SK, Das P, Kante B, Ranjan MK, Thomas DM, Mundhra S, Sahu P, Venigalla PM, Jain S, Goyal S, Golla R, Virmani S, Singh MK, Sachdeva K, Sharma R, Dash NR, Makharia G, Kedia S, Ahuja V. Kumar P, et al. Among authors: ranjan mk. Intest Res. 2023 Oct;21(4):460-470. doi: 10.5217/ir.2022.00128. Epub 2023 Mar 17. Intest Res. 2023. PMID: 36926698 Free PMC article.
Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis.
Kumar P, Vuyyuru SK, Kante B, Kedia S, Sahu P, Ranjan MK, Mundhra S, Golla R, Kumar M, Virmani S, Gupta A, Yadav N, Makharia G, Ahuja V. Kumar P, et al. Among authors: ranjan mk. Indian J Gastroenterol. 2022 Oct;41(5):446-455. doi: 10.1007/s12664-022-01252-5. Epub 2022 Nov 15. Indian J Gastroenterol. 2022. PMID: 36378484
18 results